National Health Investors, Inc. NHI
66.92
(0.24)
(0.36%)
as of 25 Sep
- Market cap
- $3.3B
- P/E
- 19.3×
Follow NHI
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
24.92 | 25.20 | 26.00 | 21.98 |
P/S ratio |
10.61 | 9.53 | 9.73 | 8.55 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
60.30 | 52.85 | 73.12 | 56.85 | |
P/B ratio |
2.53 | 2.34 | 2.57 | 2.34 | |
Price to Tangible BV |
2.53 | 2.34 | 2.57 | 2.34 | |
EV/Sales |
13.50 | 12.58 | 12.83 | 11.43 | |
EV/EBITDA |
17.37 | 16.75 | 17.73 | 16.76 | |
EV/Operating CF |
21.19 | 19.97 | 21.16 | 19.86 | |
EV/FCF |
(100.57) | (82.20) | (68.18) | (85.70) | |
Quick Ratio |
4.60 | 2.34 | 2.75 | 2.27 | |
Current Ratio |
10.64 | 7.17 | 8.20 | 6.78 | |
Net Debt/EBITDA |
14.55 | 16.09 | 16.09 | 16.46 | |
Debt/Assets |
41.23% | 41.61% | 43.94% | 43.00% | |
Debt/Equity |
0.74 | 0.76 | 0.83 | 0.81 | |
Asset Turnover |
0.14 | 0.14 | 0.14 | 0.15 | |
Operating CF/Net income |
1.91 | 1.78 | 1.34 | 1.17 | |
Capex/Depreciation |
(0.21) | (7.36) | (4.04) | (1.80) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.17% | 7.20% | 7.08% | 7.64% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
1.09% | 0.91% | 1.95% | 1.95% | |
Graham Net Nets |
(0.22) | (0.27) | (0.27) | (0.29) | |
Graham Number |
47.47 | 47.17 | 46.96 | 50.45 | |
Earnings Yield |
4.01% | 3.97% | 3.85% | 4.55% | |
Free Cash Flow Yield |
(1.27%) | (1.61%) | (1.93%) | (1.56%) | |
Revenue per Share |
1.89 | 2.26 | 2.38 | 2.50 | |
Operating CF per Share |
1.32 | 1.45 | 1.11 | 1.34 | |
Capex per Share |
(0.11) | (3.27) | (2.10) | (0.96) | |
Free Cash Flow per Share |
1.21 | (1.82) | (1.00) | 0.38 | |
Cash per Share |
1.72 | 0.42 | 0.52 | 0.63 | |
Shareholders Equity per Share |
31.40 | 32.63 | 31.51 | 32.60 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
31.40 | 32.63 | 31.51 | 32.60 | |
Free Cash Flow |
57.49 | (85.46) | (48.28) | 18.64 | |
Working Capital |
334.05 | 259.74 | 272.35 | 268.22 | |
Capital Expenditures |
(5.04) | (153.20) | (101.72) | (46.34) | |
Net Current Asset Value |
(831.90) | (965.37) | (1,057.05) | (1,070.65) | |
EV/EBIT |
24.98 | 24.15 | 25.78 | 24.89 | |
Capex to Sales |
0.06 | 1.45 | 0.88 | 0.38 | |
Net Profit Margin |
36.52% | 36.02% | 34.76% | 45.81% | |
Price to Operating Income |
19.63 | 18.30 | 19.55 | 18.62 | |
| Other line items | |||||
Average Receivables |
82.12 | 83.02 | 83.81 | 82.05 | |
Average Payables |
33.58 | 39.91 | 33.52 | 39.74 | |
Average Assets |
2,575.08 | 2,705.63 | 2,836.38 | 2,830.08 | |
Average Common Equity |
1,363.97 | 1,452.55 | 1,478.83 | 1,533.43 |
Columns are period end dates